Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.8M Buy
270,033
+491
+0.2% +$168K 0.26% 82
2026
Q1
$94.8M Buy
269,542
+4,589
+2% +$1.64M 0.3% 75
2025
Q4
$86.7M Buy
+264,953
New +$84M 0.27% 81

Other funds holding AMGN

Eurizon Capital SGR SpA's AMGN Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Amgen (AMGN) stake by 0.18% in Q2 2026, buying an estimated $168K and bringing the position to 270,033 shares worth $97.8M. The position accounts for 0.26% of the portfolio, ranked #82.

Eurizon Capital SGR SpA first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,136 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Eurizon Capital SGR SpA held 270,033 shares of Amgen worth $97.8M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 491 Amgen shares in Q2 2026, an estimated $168K.
  • Amgen made up 0.26% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #82 holding.
  • Eurizon Capital SGR SpA first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,136 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.